Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
255.87
Dollar change
+2.73
Percentage change
1.08
%
IndexS&P 500 P/E40.08 EPS (ttm)6.38 Insider Own8.84% Shs Outstand739.20M Perf Week0.80%
Market Cap189.27B Forward P/E29.54 EPS next Y8.66 Insider Trans-0.05% Shs Float674.35M Perf Month6.65%
Income4.74B PEG15.76 EPS next Q1.72 Inst Own81.85% Short Float0.86% Perf Quarter14.99%
Sales27.60B P/S6.86 EPS this Y0.89% Inst Trans-0.21% Short Ratio2.06 Perf Half Y9.27%
Book/sh72.36 P/B3.54 EPS next Y13.26% ROA5.69% Short Interest5.80M Perf Year17.65%
Cash/sh7.93 P/C32.28 EPS next 5Y2.54% ROE9.28% 52W Range182.09 - 257.09 Perf YTD10.60%
Dividend Est.0.97 (0.38%) P/FCF32.74 EPS past 5Y11.31% ROI6.67% 52W High-0.47% Beta0.84
Dividend TTM1.05 (0.41%) Quick Ratio1.37 Sales past 5Y8.35% Gross Margin58.66% 52W Low40.52% ATR (14)4.76
Dividend Ex-DateDec 28, 2023 Current Ratio1.68 EPS Y/Y TTM-34.20% Oper. Margin22.01% RSI (14)64.17 Volatility1.60% 1.87%
Employees63000 Debt/Eq0.37 Sales Y/Y TTM-12.29% Profit Margin17.18% Recom1.81 Target Price265.40
Option/ShortYes / Yes LT Debt/Eq0.33 EPS Q/Q-51.20% Payout16.45% Rel Volume0.68 Prev Close253.14
Sales Surprise4.57% EPS Surprise9.24% Sales Q/Q-23.47% EarningsJan 30 BMO Avg Volume2.81M Price255.87
SMA202.83% SMA507.45% SMA20015.95% Trades Volume1,908,641 Change1.08%
Date Action Analyst Rating Change Price Target Change
Jan-24-24Downgrade Barclays Overweight → Equal Weight $240
Dec-18-23Initiated HSBC Securities Hold
Dec-13-23Resumed Wolfe Research Peer Perform
Dec-07-23Downgrade Goldman Buy → Neutral $215 → $205
Jul-19-23Initiated Raymond James Outperform $270
May-01-23Initiated SVB Securities Outperform $300
Apr-26-23Downgrade BofA Securities Buy → Neutral $310 → $250
Apr-18-23Upgrade Wells Fargo Equal Weight → Overweight $275 → $285
Jan-05-23Downgrade Credit Suisse Outperform → Neutral $315 → $300
Dec-14-22Initiated Deutsche Bank Buy $310
Mar-02-24 10:42AM
Mar-01-24 09:00AM
Feb-29-24 11:30AM
Feb-28-24 06:00PM
Feb-27-24 04:15PM
02:38PM Loading…
Feb-25-24 02:38PM
Feb-22-24 09:01PM
04:15PM
Feb-21-24 04:15PM
Feb-17-24 01:28PM
Feb-12-24 03:03PM
Feb-09-24 01:40AM
Feb-05-24 07:30AM
Feb-01-24 11:08AM
Jan-30-24 11:14PM
01:26PM Loading…
01:26PM
11:44AM
11:08AM
09:30AM
07:10AM
06:34AM
06:17AM
06:00AM
Jan-29-24 12:56PM
08:36AM
07:30AM
Jan-26-24 08:10AM
Jan-25-24 09:15AM
Jan-23-24 10:00AM
Jan-22-24 06:00PM
04:27AM Loading…
Jan-19-24 04:27AM
Jan-17-24 12:10PM
Jan-16-24 06:15PM
Jan-10-24 06:00PM
Jan-09-24 06:15PM
09:19AM
07:30AM
Jan-08-24 04:15PM
Jan-03-24 06:00PM
Jan-02-24 06:15PM
05:00PM
Dec-27-23 06:15PM
Dec-25-23 08:14PM
Dec-21-23 04:30PM
09:28AM
Dec-19-23 10:56AM
Dec-18-23 06:00PM
04:43AM
Dec-14-23 05:40AM
Dec-13-23 08:12PM
04:06PM
Dec-11-23 06:00PM
09:54AM
Dec-07-23 09:54AM
09:31AM
08:31AM
Dec-06-23 08:09AM
07:41AM
07:30AM
Dec-05-23 06:00PM
04:30PM
12:32PM
Dec-04-23 04:01PM
Nov-29-23 06:00PM
Nov-27-23 10:00AM
Nov-23-23 11:30AM
Nov-22-23 01:13PM
10:05AM
Nov-21-23 04:15PM
Nov-20-23 06:52AM
Nov-19-23 07:16PM
Nov-17-23 07:00AM
Nov-16-23 12:01PM
Nov-14-23 09:26AM
Nov-13-23 04:28PM
Nov-10-23 06:10AM
Nov-06-23 04:33PM
04:13PM
04:00PM
12:18PM
Nov-05-23 07:08AM
Nov-01-23 05:30PM
02:21PM
07:00AM
Oct-31-23 07:30AM
Oct-27-23 01:21PM
12:43PM
Oct-25-23 11:54AM
Oct-24-23 10:13PM
12:56PM
12:13PM
11:58AM
09:35AM
09:30AM
07:15AM
06:07AM
06:00AM
Oct-23-23 02:00AM
Oct-20-23 06:00PM
04:50AM
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Raskas DanielSVP - Corporate DevelopmentFeb 26Option Exercise58.4823,7571,389,30961,859Feb 27 05:01 PM
Raskas DanielSVP - Corporate DevelopmentFeb 26Sale252.0023,7575,986,76438,102Feb 27 05:01 PM
LOHR WALTER GDirectorFeb 15Option Exercise52.563,289172,87017,418Feb 16 05:01 PM
LOHR WALTER GDirectorFeb 15Sale251.153,289826,03214,129Feb 16 05:01 PM
Couchara GeorgeannSVP, Human ResourcesFeb 13Option Exercise70.712,622185,4146,022Feb 14 05:00 PM
Couchara GeorgeannSVP, Human ResourcesFeb 13Sale242.672,622636,2904,244Feb 14 05:00 PM
List TeriDirectorFeb 06Option Exercise52.563,289172,87023,015Feb 08 05:00 PM
List TeriDirectorFeb 06Sale248.323,289816,72419,726Feb 08 05:00 PM
Gutierrez-Ramos Jose-CarlosSVP, Chief Science OfficerAug 21Sale250.54590147,8196,939Aug 22 05:00 PM
Raskas DanielSVP - Corporate DevelopmentJul 28Option Exercise56.7011,213635,77749,501Aug 01 05:03 PM
Zerhouni Elias A.DirectorJul 28Option Exercise50.803,490177,29230,523Aug 01 05:02 PM
SCHWIETERS JOHN TDirectorJul 28Option Exercise50.803,490177,29222,583Aug 01 05:02 PM
FILLER LINDADirectorJul 28Option Exercise59.172,922172,89541,074Aug 01 05:00 PM
Raskas DanielSVP - Corporate DevelopmentJul 28Sale260.6511,2132,922,65238,288Aug 01 05:03 PM
FILLER LINDADirectorJul 28Sale260.2510,1902,651,97838,152Aug 01 05:00 PM
Weidemanis JoakimExecutive Vice PresidentJul 26Option Exercise56.7022,4391,272,291111,128Jul 27 05:01 PM
List TeriDirectorJul 26Option Exercise50.803,490177,29220,984Jul 27 05:00 PM
Weidemanis JoakimExecutive Vice PresidentJul 26Sale263.4222,4395,910,83288,689Jul 27 05:01 PM
List TeriDirectorJul 26Sale263.303,490918,91717,494Jul 27 05:00 PM
Raskas DanielSVP - Corporate DevelopmentMay 31Option Exercise57.9019,8471,149,14158,520Jun 01 05:00 PM
Raskas DanielSVP - Corporate DevelopmentMay 31Sale228.5019,8474,535,04038,673Jun 01 05:00 PM
LOHR WALTER GDirectorMay 05Option Exercise50.803,490177,29215,605May 08 05:08 PM
LOHR WALTER GDirectorMay 05Sale240.883,490840,68512,115May 08 05:08 PM
Weidemanis JoakimExecutive Vice PresidentMay 04Option Exercise57.909,934575,179101,357May 05 05:01 PM
Weidemanis JoakimExecutive Vice PresidentMay 04Sale245.279,9342,436,51291,423May 05 05:01 PM
Couchara GeorgeannSVP, Human ResourcesMay 04Sale245.27695170,4631,565May 05 05:00 PM
Gutierrez-Ramos Jose-CarlosSVP, Chief Science OfficerMay 01Sale242.19500121,0967,529May 02 05:01 PM